Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure AwarenessHeart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissions Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Sep 3 2020 | Seeking Applications for Journal of Cardiac Failure, Editor-in-Chief HFSA News Journal of Cardiac Failure Read More Sep 2 2020 | Jardiance® reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25% in adults with and without diabetes who had heart failure with reduced ejection fraction Industry News Industry Read More Sep 2 2020 | ACC Seeks Comments on Updated Expert Consensus Decision Pathway For HF Treatment Optimization Practice News Read More Sep 1 2020 | Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial Industry News Industry Read More Aug 29 2020 | HFSA Announces Search for Editor-in-Chief for Journal of Cardiac Failure HFSA News Journal of Cardiac Failure Professional Development Read More Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Sep 3 2020 | Seeking Applications for Journal of Cardiac Failure, Editor-in-Chief HFSA News Journal of Cardiac Failure Read More
Sep 2 2020 | Jardiance® reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25% in adults with and without diabetes who had heart failure with reduced ejection fraction Industry News Industry Read More
Sep 2 2020 | ACC Seeks Comments on Updated Expert Consensus Decision Pathway For HF Treatment Optimization Practice News Read More
Sep 1 2020 | Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial Industry News Industry Read More
Aug 29 2020 | HFSA Announces Search for Editor-in-Chief for Journal of Cardiac Failure HFSA News Journal of Cardiac Failure Professional Development Read More
